JP Morgan Chase’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

JP Morgan Chase’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$12K	–	5412
2016 Q4	$12K	Buy	+1,000	New	+$12K	﹤0.01%	4780

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JP Morgan Chase's ARIA Position: Q1 2017 in Review

JP Morgan Chase sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 229,736 shares — an estimated $2.86M sold.

JP Morgan Chase first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $12.4M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

JP Morgan Chase reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
JP Morgan Chase sold 229,736 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.86M.
JP Morgan Chase first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
JP Morgan Chase's Ariad Pharmaceuticals Inc position peaked at $12.4M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.